Successful treatment of lichen planus with sulfasalazine in 20 patients

International Journal of Dermatology

Volumn 44, Issue 2, 2005, Pages 158-162

  Bauza A ^a   España, Agustín ^a   Gil, P ^a   Lloret, P ^a   Vazquez Doval F J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; RETINOID DERIVATIVE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG ERUPTION; DRUG EXPOSURE; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; FEVER; FOLLOW UP; HEADACHE; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; LEUKOPENIA; LICHEN PLANUS; LIVER FUNCTION TEST; MALE; MUSCLE WEAKNESS; PROSPECTIVE STUDY; PRURITUS; RELAPSE; STOMACH PAIN; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LICHEN PLANUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 14544308953     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02070.x     Document Type: Article

References (12)

1. Daoud MS, Pittelkow MR. Lichen planus. In: Fitzpatrick, Eisen, Wolff, et al., eds Fitzpatrick's Dermatology in General Medicine, 5th edn. EDZ, Vol. 1. McGraw-Hill, 1999: 561-580.
2. Gupta AK, Ellis CN, Siegel MT, et al. Sulfasalazine improves psoriasis: a double-blind analysis. Arch Dermatol 1990; 126: 487-493.
3. Gupta AK, Ellis CN, Siegel MT, et al. Sulfasalazine: a potential psoriasis therapy? J Am Acad Dermatol 1989; 20: 797-800.
4. Yamamoto T, Osaki T. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995; 104: 784-788.
5. Simark-Mattsson C, Bergenhohz G, Jontell M, et al. Distribution of interleukin-2-4-10, tumor necrosis factor-α and transforming growth factor-β mRNAs in oral lichen planus. Arch Oral Biol 1999; 44: 499-507.
6. Walton LJ, Thornhill MH, Farthing PM. VCAM-1 and ICAM-1 are expressed by Langerhans cells, macrophages and endothelial cells in oral lichen planus. J Oral Pathol Med 1994; 23: 262-268.
7. Regezi JA, Dekker NP, MacPhail LA, et al. Vascular adhesion molecules in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81: 682-690.
8. Groves RW, Ross EL, Barker JN, et al. Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma. J Am Acad Dermatol 1993; 29: 67-72.
9. Feeley BT, Park AK, Grant Hoyt E, et al. Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants. J Heart Lung Transplant 1999; 18: 1088-95.
10. Kang BY, Chung SW, Im S-Y, et al. Sulfasalazine prevents T-helper 1 immune response by suppressing interleukin-12 production in macrophages. Immunology 1999; 98: 98-103.
11. Alstead EM, Wilson AGM, Farthing MJG. Lichen planus and mesalazine. J Clin Gastroenterol 1991; 113: 335-337.
12. Kaplan S, McDonald E, Marino C. Lichen planus in patients with Rheumatoid Arthritis treated with sulphasalazine. J Rheumatol 1995; 22: 191.